Susquehanna International Group’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-55,000
Closed -$240K 13510
2025
Q4
$240K Buy
+55,000
New +$297K ﹤0.01% 10471
2025
Q3
Sell
-21,800
Closed -$62.6K 12959
2025
Q2
$62.6K Buy
+21,800
New +$57.6K ﹤0.01% 12040

Other funds holding GNLX

Susquehanna International Group's GNLX Position: Q1 2026 in Review

Susquehanna International Group reduced its Genelux (GNLX) stake by 71% in Q1 2026, selling an estimated $421K and leaving 61,980 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #12003.

Susquehanna International Group first reported a position in GNLX in Q2 2024 and has held it in 6 quarters since. The position peaked at $943K in Q4 2025. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Susquehanna International Group held 61,980 shares of Genelux worth $150K as of Q1 2026.
  • Susquehanna International Group sold 154,343 Genelux shares in Q1 2026, an estimated $421K.
  • Genelux made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12003 holding.
  • Susquehanna International Group first reported a position in Genelux in Q2 2024 and has held it in 6 quarters since.
  • Susquehanna International Group's Genelux position peaked at $943K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.